Latest Advances

  • Condition: Congenital Dyserythropoietic Anemia Type I
  • Journal: European journal of haematology
  • Treatment Used: Pegylated interferon ?2a therapy
  • Number of Patients: 7
  • Published —
The study researched the use of Pegylated interferon ?2a therapy in treating congenital dyserythropoietic anemia type I.
  • Condition: Severe hemosiderosis, disturbed BM microenvironment
  • Journal: Pediatric transplantation
  • Treatment Used: haploidentical bone marrow transplantation with PT-CY
  • Number of Patients: 1
  • Published —
This report describes the case of a twelve year old male with severe hemosiderosis, disturbed bone marrow (BM) microenvironment which lead to experience graft failures.
Showing 1-2 of 2